White label ELPA - ClinicalTrials.eu

Study of methotrexate compared to placebo for treating pain in patients with erosive hand osteoarthritis

Not recruiting

3 1 1
Investigated diseases:
- Osteoarthritis
Investigated drugs:
- Placebo
- Methotrexate
Study on the Safety and Effectiveness of Rozanolixizumab and Immunoglobulins in Children with Generalized Myasthenia Gravis

Not recruiting

3 1 1 1
Investigated drugs:
- Immunoglobulins, Normal Human
- Rozanolixizumab
Study on Nipocalimab for Adults with Warm Autoimmune Hemolytic Anemia

Not recruiting

4 1 1
Investigated diseases:
- Autoimmune haemolytic anaemia
Investigated drugs:
- Nipocalimab
- Sodium Chloride
+3
Study on the Effects of a Higher Dose of Ocrelizumab for Adults with Relapsing Multiple Sclerosis

Not recruiting

3 1 1
Investigated drugs:
+4
Study on the Effectiveness and Safety of JNJ-73763989 and Tenofovir Alafenamide in Patients with Hepatitis B and D Co-infection

Not recruiting

2 1 1
Investigated diseases:
- Hepatitis B
- Hepatitis D
Investigated drugs:
Study on IO102-IO103 and Pembrolizumab for Patients with Metastatic Lung, Head and Neck, or Bladder Cancer

Not recruiting

2 1 1 1
Investigated diseases:
Investigated drugs:
- Io103 Acetate
- Pembrolizumab
Study on the Effectiveness and Safety of Idecabtagene Vicleucel for Patients with Relapsed or Refractory Multiple Myeloma

Not recruiting

2 1 1
Investigated diseases:
- Plasma cell myeloma
- Plasma cell myeloma refractory
Investigated drugs:
- Idecabtagene Vicleucel
Study on the Effectiveness and Safety of Remibrutinib Compared to Placebo and Omalizumab in Adults with Chronic Spontaneous Urticaria Uncontrolled by Antihistamines

Not recruiting

3 1 1
Investigated diseases:
- Chronic spontaneous urticaria
Investigated drugs:
- Omalizumab
- Remibrutinib
+4
Study on Erythromycin Lactobionate for Improving Gastric Emptying in Stroke Patients Needing Mechanical Thrombectomy

Not recruiting

3 1 1 1
Investigated diseases:
- Cerebrovascular accident
- Thrombectomy
Investigated drugs:
- Erythromycin Lactobionate
Study of BDC-1001 and Pertuzumab for Patients with HER2-Positive Metastatic Breast Cancer Previously Treated with Trastuzumab Deruxtecan

Not recruiting

2 1 1 1
Investigated diseases:
- Breast cancer metastatic
Investigated drugs:
- Bdc-1001
- Pertuzumab

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies